What is the current stock price of StemRIM (4599.T)?

As of the latest market data, StemRIM (4599.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does StemRIM (4599.T) pay a dividend?

Based on current data, StemRIM does not have a confirmed active dividend policy.

What is the market cap of StemRIM?

The current market capitalization of StemRIM (4599.T) is approximately unavailable.

4599.T

StemRIM·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2019-08-09

Beta

0.94

Websitewww.stemrim.com↗